tradingkey.logo
tradingkey.logo
Search

Oruka Therapeutics Inc

ORKA
Add to Watchlist
96.510USD
-1.350-1.38%
Close 07-31 16:00ETQuotes delayed by 15 min
4.84BMarket Cap
LossP/E TTM

ORKA Financials

See Oruka Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Oruka Therapeutics Inc Earnings Date

Latest Release
May 13, 2026
EPS / Forecast
-0.58/-0.55
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-2.31
53.65%
Analyst Rating
STRONG BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-14.47%-0.58
7.80%-0.54
63.96%-0.69
73.65%-0.58
69.69%-0.50
35.08%-0.59
-60.77%-1.91
-79.73%-2.22
-48.31%-1.66
7.39%-0.91
---1.19
---1.23
---1.12
---0.98
---7.29
----
----
----
----
----
Net Profit
-51.53%-31.82M
-14.75%-29.58M
-5.78%-30.28M
-817.63%-24.57M
-945.25%-21.00M
-2267.40%-25.78M
-1910.04%-28.62M
-80.95%-2.68M
-49.26%-2.01M
7.24%-1.09M
38.96%-1.42M
52.97%-1.48M
58.86%-1.35M
79.32%-1.17M
50.49%-2.33M
34.90%-3.15M
20.20%-3.27M
-10.75%-5.68M
-136.66%-4.71M
-271.27%-4.83M
Debt to assets ratio
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
----
--0.00%
--0.00%
----
----
----
----
----
Operating profit
-45.24%-36.43M
-13.57%-34.43M
-15.81%-34.10M
-810.60%-28.43M
-910.72%-25.09M
-1806.79%-30.32M
-1420.34%-29.45M
-58.24%-3.12M
-38.20%-2.48M
-2.71%-1.59M
24.10%-1.94M
38.71%-1.97M
45.19%-1.80M
72.75%-1.55M
45.89%-2.55M
33.45%-3.22M
20.11%-3.28M
-10.81%-5.68M
-136.98%-4.72M
-269.24%-4.84M
Net Profit
-51.53%-31.82M
-14.75%-29.58M
-5.78%-30.28M
-817.63%-24.57M
-945.25%-21.00M
-2267.40%-25.78M
-1910.04%-28.62M
-80.95%-2.68M
-49.26%-2.01M
7.24%-1.09M
38.96%-1.42M
52.97%-1.48M
58.86%-1.35M
79.32%-1.17M
50.49%-2.33M
34.90%-3.15M
20.20%-3.27M
-10.75%-5.68M
-136.66%-4.71M
-271.27%-4.83M
Current assets
12.26%395.25M
-8.76%343.86M
-13.99%355.16M
881.70%332.01M
860.14%352.08M
902.52%376.87M
961.78%412.95M
-17.02%33.82M
-12.07%36.67M
-11.96%37.59M
-12.70%38.89M
-14.48%40.76M
-17.49%41.70M
-21.54%42.70M
-25.33%44.55M
-26.45%47.66M
-26.47%50.54M
8.91%54.42M
14.88%59.67M
459.86%64.79M
Total current liabilities
41.88%16.63M
17.87%15.37M
16.23%20.97M
852.79%12.11M
641.49%11.72M
1947.57%13.04M
1718.45%18.04M
-20.66%1.27M
24.88%1.58M
-43.73%637.00K
-48.79%992.00K
-42.97%1.60M
-53.44%1.27M
-67.64%1.13M
-39.13%1.94M
-23.98%2.81M
-5.59%2.72M
-0.03%3.50M
108.38%3.18M
178.24%3.69M
Total assets
33.77%504.48M
23.38%488.62M
22.98%509.25M
956.07%357.42M
927.39%377.11M
945.98%396.02M
956.78%414.09M
-17.62%33.84M
-12.73%36.71M
-12.12%37.86M
-12.86%39.18M
-14.59%41.08M
-17.55%42.06M
-21.56%43.09M
-25.30%44.97M
-26.38%48.10M
-26.26%51.01M
8.91%54.92M
15.79%60.19M
461.66%65.34M
Total liabilities
43.38%17.76M
20.94%16.69M
18.96%22.46M
983.87%13.78M
683.49%12.39M
1540.67%13.80M
1452.71%18.88M
-31.11%1.27M
3.47%1.58M
-40.44%841.00K
-45.67%1.22M
-41.20%1.84M
-50.33%1.53M
-63.62%1.41M
-37.69%2.24M
-24.02%3.14M
-6.05%3.08M
-0.69%3.88M
135.23%3.59M
210.99%4.13M
Total equity
33.45%486.72M
23.47%471.93M
23.17%486.79M
954.99%343.64M
938.36%364.73M
932.47%382.22M
940.90%395.21M
-16.99%32.57M
-13.34%35.13M
-11.17%37.02M
-11.14%37.97M
-12.73%39.24M
-15.45%40.53M
-18.36%41.67M
-24.51%42.73M
-26.54%44.96M
-27.27%47.94M
9.72%51.04M
12.18%56.60M
493.96%61.21M
Net operating income
-12.98%-23.58M
-20.07%-22.59M
38.03%-21.60M
-778.70%-23.14M
-1265.77%-20.87M
-1682.01%-18.82M
-1988.50%-34.86M
-279.54%-2.63M
4.20%-1.53M
29.32%-1.06M
33.19%-1.67M
73.53%-694.00K
62.89%-1.59M
69.80%-1.49M
48.71%-2.50M
29.52%-2.62M
17.74%-4.30M
-65.18%-4.95M
-143.26%-4.87M
-257.01%-3.72M
Net investment
-133.68%-14.44M
93.33%-22.02M
-71507.60%-122.45M
--4.86M
--42.87M
---329.96M
---171.00K
--0.00
--0.00
--0.00
--0.00
--0.00
100.00%0.00
100.00%0.00
100.00%0.00
100.00%0.00
66.67%-2.00K
46.15%-7.00K
---14.00K
-433.33%-16.00K
Net financing
--40.60M
156.65%298.00K
-62.25%169.91M
678.57%109.00K
----
---526.00K
--450.05M
--14.00K
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00

FAQs

What are the current assets of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2025 earnings report, its current assets were 343.86M, with a year-on-year change of -8.76.

What are the total assets of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2025 earnings report, its total assets of Oruka Therapeutics Inc were 488.62M, with a year-on-year change of 23.38.

What are the total liabilities of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2025 earnings report, its total liabilities of Oruka Therapeutics Inc were 16.69M, with a year-on-year change of 20.94.

What is the total equity of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2025 earnings report, its total equity of Oruka Therapeutics Inc was 471.93M, with a year-on-year change of 23.47.

What is the net operating income of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2025 earnings report, its net operating income of Oruka Therapeutics Inc was -122.05M, with a year-on-year change of -38.50.

What is the net investment of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2025 earnings report, its net investment of Oruka Therapeutics Inc was -96.75M, with a year-on-year change of 70.69.

What is the net financing of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2025 earnings report, its net financing of Oruka Therapeutics Inc was 170.31M, with a year-on-year change of -62.11.

What is the Earnings Per Share (EPS) of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.31, with a year-on-year change of 53.65.

What is the net income of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2025 earnings report, its net income was -105.43M, with a year-on-year change of -25.93.

What is the Return on Equity (ROE) of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -24.86, with a year-on-year change of 38.20.

What is the Return on Assets (ROA) of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -23.84, with a year-on-year change of 38.24.

What is the operating profit of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2025 earnings report, its operating profit was -122.05M, with a year-on-year change of -38.50.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.